GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RIV Capital Inc (OTCPK:CNPOF) » Definitions » ROE % Adjusted to Book Value

CNPOF (RIV Capital) ROE % Adjusted to Book Value : 0.00% (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is RIV Capital ROE % Adjusted to Book Value?

RIV Capital's ROE % for the quarter that ended in Sep. 2024 was 0.00%. RIV Capital's PB Ratio for the quarter that ended in Sep. 2024 was N/A. RIV Capital's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was N/A.


RIV Capital ROE % Adjusted to Book Value Historical Data

The historical data trend for RIV Capital's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RIV Capital ROE % Adjusted to Book Value Chart

RIV Capital Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22
ROE % Adjusted to Book Value
- 0.75 -19.12 -43.28 -24.58

RIV Capital Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -147.00 - -197.07 -195.55 -

Competitive Comparison of RIV Capital's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, RIV Capital's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RIV Capital's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, RIV Capital's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where RIV Capital's ROE % Adjusted to Book Value falls into.



RIV Capital ROE % Adjusted to Book Value Calculation

RIV Capital's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2022 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-16.47% / 0.67
=-24.58%

RIV Capital's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


RIV Capital ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of RIV Capital's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


RIV Capital Business Description

Traded in Other Exchanges
Address
40 King Street West, Suite 2504, Toronto, ON, CAN, M5H 3Y2
RIV Capital Inc is a venture capital investment and operating platform structured to pursue investment opportunities in the cannabis sector. The company has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the cannabis sector. The investments take the form of production-linked royalties, secured debt, newly formed joint ventures, and a variety of equity and equity-linked instruments.